Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
1802908-04-8
1802907-97-6
2245150-18-7
1807518-68-8 | Peg3-bis(phosphonic acid trimethylsilyl ester) | AA00I04W | MFCD26127820
1820579-48-3 | D-Ala-d-leu-oh tfa | AA00I0BK | MFCD26793858
1820641-46-0 | 4-Ethanesulfonyl-3-morpholinonitrobenzene | AA00I0JT | MFCD25953890
1820686-35-8 | Methyl 7-bromo-1-propyl-1,2,3-benzotriazole-5-carboxylate | AA00I0S5 | MFCD25953926
1820718-53-3 | N-Boc-3-(4-formylphenylsulfanyl)azetidine | AA00I0ZP | MFCD28385217
1823898-84-5 | 5-Bromo-6-(1-fluoro-1-methyl-ethyl)-3H-pyrimidin-4-one | AA00I18Q | MFCD26954820
1845706-34-4 | N-(2-Methoxyethyl)-N-(2-nitrophenyl)methanesulfonamide | AA00I1F6 | MFCD28515393
186412-62-4 | Piperazine, 1-[(phenylmethyl)sulfonyl]- | AA00I1Q9 | MFCD03444529
1887246-43-6 | 5-Bromo-2-chloro-3-(2-methoxyethoxy)pyridine | AA00I2OK | MFCD29764419
19361-59-2 | 2,3,4-Trichlorobenzaldehyde | AA00I2X9 | MFCD00204047